I was not aware of that. Another good reason to be skeptical.
From the footnotes of the paper mentioned above:
CONFLICTS OF INTEREST: AH, BY, ZY work for AVIV Scientific LTD. ES is a shareholder at AVIV Scientific LTD.
FUNDING: The study was funded by a research grant from the Sagol network for neuroscience established by Mr. Sami Sagol.
It sounds like the initial research study was funded by a bunch of angel investors⊠which to me seems highly odd⊠and which makes the paper sound more like a piece of marketing literature than a true scientific study.
So - just to be clear, my understanding is that the angel investors funded the research, that was then used to fundraise for the company⊠hmmmm, this is highly unusual in my experience in the silicon valley. I donât think youâd never see anything like this here.
Doing a little research - they have a ton of money going into this venture, so they are highly conflicted:
https://www.crunchbase.com/organization/aviv-scientific
Aviv Scientific Raises $40 Million in Series B Funding to Create the Worldâs First High Dimensional OMICS Database of the Aging Process
Expansion of Global Network of Medical Clinics Initiates a New Era in Aging and Brain Health
September 22, 2021 08:00 AM Eastern Daylight Time
TEL AVIVâ(BUSINESS WIRE)âToday world leader in research and clinical treatment of age-related cognitive and functional decline to maximize human performance, Aviv Scientific, announces the closing of $40 million in a oversubscribed Series B funding round. Led by Israelâs largest public medical services conglomerate, Danel LTD; Jeff Horingâs Deep Insight Fund; the countryâs most successful high-tech angels and entrepreneurs; international longevity and healthspan optimization focused investors; the Series B fundraise will accelerate the global rollout of its network of medical clinics and the development of the Aviv Aging Database. For the first time, in depth comprehensive OMICS data detailing the aging process in healthy adults will be captured, expediting the development of therapeutics and approaches to notably extend healthspan, and ultimately lifespan, in humans.
âThe new round of funding is a testament to our outstanding clinical outcomes, world-class team, strategic partnerships and cutting-edge technology. We look forward to seeing sustained success and are inspired by the strong support from investors who share our vision.â
Based on an exclusive partnership with the worldâs largest hyperbaric medicine and research facility, the Sagol Center at Shamir Medical Center in Israel, the Aviv Medical Program was developed over the past decade, combining unique protocols of Hyperbaric Oxygen Therapy (HBOT) with a proprietary personalized program of cognitive and physical training. More than 1,000 people worldwide have already been treated according to Avivâs progressive twelve-week program, currently offered in Florida and Dubai at Aviv Clinics.
https://www.businesswire.com/news/home/20210922005272/en/Aviv-Scientific-Raises-40-Million-in-Series-B-Funding-to-Create-the-Worldâs-First-High-Dimensional-OMICS-Database-of-the-Aging-Process